173 related articles for article (PubMed ID: 7891793)
1. Prevention of thrombotic complications of the nephrotic syndrome by the low-molecular-weight heparin enoxaparin.
Rostoker G; Durand-Zaleski I; Petit-Phar M; Ben Maadi A; Jazaerli N; Radier C; Rahmouni A; Mathieu D; Vasile N; Rosso J
Nephron; 1995; 69(1):20-8. PubMed ID: 7891793
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
[TBL] [Abstract][Full Text] [Related]
3. Venovenous Extracorporeal Membrane Oxygenation With Prophylactic Subcutaneous Anticoagulation Only: An Observational Study in More Than 60 Patients.
Krueger K; Schmutz A; Zieger B; Kalbhenn J
Artif Organs; 2017 Feb; 41(2):186-192. PubMed ID: 27256966
[TBL] [Abstract][Full Text] [Related]
4. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery.
De A; Roy P; Garg VK; Pandey NK
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):57-61. PubMed ID: 19844176
[TBL] [Abstract][Full Text] [Related]
5. Comparison of different dose regimens of enoxaparin in deep vein thrombosis therapy in pregnancy.
Narin C; Reyhanoglu H; Tülek B; Onoglu R; Ege E; Sarigül A; Yeniterzi M; Durmaz I
Adv Ther; 2008 Jun; 25(6):585-94. PubMed ID: 18568442
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis.
Pini M; Aiello S; Manotti C; Pattacini C; Quintavalla R; Poli T; Tagliaferri A; Dettori AG
Thromb Haemost; 1994 Aug; 72(2):191-7. PubMed ID: 7831650
[TBL] [Abstract][Full Text] [Related]
7. The home treatment of deep vein thrombosis with low molecular weight heparin, forced mobilisation and compression.
Labas P; Ohrádka B; Vladimír J; Cambal M
Int Angiol; 2000 Dec; 19(4):303-7. PubMed ID: 11305727
[TBL] [Abstract][Full Text] [Related]
8. [Superior sagittal sinus thrombosis and nephrotic syndrome: favorable outcome with low molecular weight heparin].
de Saint-Martin A; Terzic J; Christmann D; Knab MC; Peter MO; Fischbach M
Arch Pediatr; 1997 Sep; 4(9):849-52. PubMed ID: 9345566
[TBL] [Abstract][Full Text] [Related]
9. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis.
Superficial Thrombophlebitis Treated By Enoxaparin Study Group
Arch Intern Med; 2003 Jul; 163(14):1657-63. PubMed ID: 12885680
[TBL] [Abstract][Full Text] [Related]
10. A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group.
Bergmann JF; Neuhart E
Thromb Haemost; 1996 Oct; 76(4):529-34. PubMed ID: 8902991
[TBL] [Abstract][Full Text] [Related]
11. The effect of enoxaparin in prevention of deep venous thrombosis in hip and knee surgery--a comparison with the dihydroergotamine-heparin combination.
Perhoniemi V; Vuorinen J; Myllynen P; Kivioja A; Lindevall K
Ann Chir Gynaecol; 1996; 85(4):359-63. PubMed ID: 9014067
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary embolism and renal vein thrombosis in patients with nephrotic syndrome: prospective evaluation of prevalence and risk factors with CT.
Zhang LJ; Zhang Z; Li SJ; Meinel FG; Nance JW; Zhou CS; Zhao YE; Schoepf UJ; Lu GM
Radiology; 2014 Dec; 273(3):897-906. PubMed ID: 25072187
[TBL] [Abstract][Full Text] [Related]
13. The prognosis of renal vein thrombosis: a re-evaluation of 27 cases.
Laville M; Aguilera D; Maillet PJ; Labeeuw M; Madonna O; Zech P
Nephrol Dial Transplant; 1988; 3(3):247-56. PubMed ID: 3140096
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of enoxaparin to prevent deep vein thrombosis after hip arthroplasty.
Colwell CW; Spiro TE
Clin Orthop Relat Res; 1995 Oct; (319):215-22. PubMed ID: 7554633
[TBL] [Abstract][Full Text] [Related]
15. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis.
Villa E; Cammà C; Marietta M; Luongo M; Critelli R; Colopi S; Tata C; Zecchini R; Gitto S; Petta S; Lei B; Bernabucci V; Vukotic R; De Maria N; Schepis F; Karampatou A; Caporali C; Simoni L; Del Buono M; Zambotto B; Turola E; Fornaciari G; Schianchi S; Ferrari A; Valla D
Gastroenterology; 2012 Nov; 143(5):1253-1260.e4. PubMed ID: 22819864
[TBL] [Abstract][Full Text] [Related]
16. Prophylaxis of thromboembolic events in patients with nephrotic syndrome.
Pincus KJ; Hynicka LM
Ann Pharmacother; 2013 May; 47(5):725-34. PubMed ID: 23613095
[TBL] [Abstract][Full Text] [Related]
17. [Outpatient treatment of deep vein thrombosis with low-molecular-weight heparins. Experience from an open, prospective study in daily practice].
Heidenreich C; Hohmann V; Bramlage P
Med Klin (Munich); 2009 Jan; 104(1):20-7. PubMed ID: 19142593
[TBL] [Abstract][Full Text] [Related]
18. [Renal vein thrombosis: a complication of the nephrotic syndrome? (author's transl)].
Kampf D; Becker H; Höfer W; Baethke R
Med Klin; 1977 Sep; 72(36):1435-42. PubMed ID: 904540
[TBL] [Abstract][Full Text] [Related]
19. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
[TBL] [Abstract][Full Text] [Related]
20. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis.
Levine M; Gent M; Hirsh J; Leclerc J; Anderson D; Weitz J; Ginsberg J; Turpie AG; Demers C; Kovacs M
N Engl J Med; 1996 Mar; 334(11):677-81. PubMed ID: 8594425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
